• レポートコード:D005-00113 • 出版社/出版日:GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、101ページ • 納品方法:Eメール • 産業分類:医療・製薬 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、細菌ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。細菌ワクチンの種類別市場規模(莢膜多糖ワクチン、トキソイドワクチン、精製タンパク質ワクチン、弱毒生菌ワクチン、殺菌菌ワクチン、その他)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Sanofi、Merck、Emergent BioDefense Operations Lansing、GlaxoSmithKline、Serum Institute of India、PaxVax ・地域別グローバル市場分析 2015年-2020年 ・細菌ワクチンの北米市場(アメリカ、カナダ、メキシコ) ・細菌ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・細菌ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・細菌ワクチンの南米市場(ブラジル、アルゼンチン) ・細菌ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:莢膜多糖ワクチン、トキソイドワクチン、精製タンパク質ワクチン、弱毒生菌ワクチン、殺菌菌ワクチン、その他 ・用途別分析:病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Bacterial Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Bacterial Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Bacterial Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Bacterial Vaccines market has been segmented into:
Capsular Polysaccharide Vaccines
Toxoid Vaccines
Purified Protein Vaccines
Live Attenuated Bacterial Vaccines
Killed Bacterial Vaccines
Others
By Application, Bacterial Vaccines has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bacterial Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Bacterial Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bacterial Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Bacterial Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Bacterial Vaccines Market Share Analysis
Bacterial Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bacterial Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bacterial Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Bacterial Vaccines are:
Pfizer
Sanofi
Merck
Emergent BioDefense Operations Lansing
GlaxoSmithKline
Serum Institute of India
PaxVax
Table of Contents
1 Bacterial Vaccines Market Overview
1.1 Product Overview and Scope of Bacterial Vaccines
1.2 Classification of Bacterial Vaccines by Type
1.2.1 Global Bacterial Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Bacterial Vaccines Revenue Market Share by Type in 2019
1.2.3 Capsular Polysaccharide Vaccines
1.2.4 Toxoid Vaccines
1.2.5 Purified Protein Vaccines
1.2.6 Live Attenuated Bacterial Vaccines
1.2.7 Killed Bacterial Vaccines
1.2.8 Others
1.3 Global Bacterial Vaccines Market by Application
1.3.1 Overview: Global Bacterial Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Bacterial Vaccines Market by Regions
1.4.1 Global Bacterial Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Bacterial Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Bacterial Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Bacterial Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bacterial Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Bacterial Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bacterial Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Emergent BioDefense Operations Lansing
2.4.1 Emergent BioDefense Operations Lansing Details
2.4.2 Emergent BioDefense Operations Lansing Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Emergent BioDefense Operations Lansing SWOT Analysis
2.4.4 Emergent BioDefense Operations Lansing Product and Services
2.4.5 Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Serum Institute of India SWOT Analysis
2.6.4 Serum Institute of India Product and Services
2.6.5 Serum Institute of India Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 PaxVax
2.7.1 PaxVax Details
2.7.2 PaxVax Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 PaxVax SWOT Analysis
2.7.4 PaxVax Product and Services
2.7.5 PaxVax Bacterial Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Bacterial Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Bacterial Vaccines Players Market Share
3.2.2 Top 10 Bacterial Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Bacterial Vaccines Revenue and Market Share by Regions
4.2 North America Bacterial Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Bacterial Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Bacterial Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Bacterial Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Bacterial Vaccines Revenue and Growth Rate (2015-2020)
5 North America Bacterial Vaccines Revenue by Countries
5.1 North America Bacterial Vaccines Revenue by Countries (2015-2020)
5.2 USA Bacterial Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Bacterial Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Bacterial Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Bacterial Vaccines Revenue by Countries
6.1 Europe Bacterial Vaccines Revenue by Countries (2015-2020)
6.2 Germany Bacterial Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Bacterial Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Bacterial Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Bacterial Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Bacterial Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Bacterial Vaccines Revenue by Countries
7.1 Asia-Pacific Bacterial Vaccines Revenue by Countries (2015-2020)
7.2 China Bacterial Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Bacterial Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Bacterial Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Bacterial Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Bacterial Vaccines Revenue and Growth Rate (2015-2020)
8 South America Bacterial Vaccines Revenue by Countries
8.1 South America Bacterial Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Bacterial Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Bacterial Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Bacterial Vaccines by Countries
9.1 Middle East & Africa Bacterial Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Bacterial Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Bacterial Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Bacterial Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Bacterial Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Bacterial Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Bacterial Vaccines Market Forecast by Type (2019-2024)
10.3 Capsular Polysaccharide Vaccines Revenue Growth Rate (2015-2025)
10.4 Toxoid Vaccines Revenue Growth Rate (2015-2025)
10.5 Purified Protein Vaccines Revenue Growth Rate (2015-2025)
10.6 Live Attenuated Bacterial Vaccines Revenue Growth Rate (2015-2025)
10.7 Killed Bacterial Vaccines Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Bacterial Vaccines Market Segment by Application
11.1 Global Bacterial Vaccines Revenue Market Share by Application (2015-2020)
11.2 Bacterial Vaccines Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Bacterial Vaccines Market Size Forecast (2021-2025)
12.1 Global Bacterial Vaccines Market Size Forecast (2021-2025)
12.2 Global Bacterial Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Bacterial Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Bacterial Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Bacterial Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Bacterial Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Bacterial Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Bacterial Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bacterial Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bacterial Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Bacterial Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Bacterial Vaccines Major Business
Table 7. Pfizer Bacterial Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Bacterial Vaccines Product and Solutions
Table 10. Pfizer Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Bacterial Vaccines Major Business
Table 13. Sanofi Bacterial Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Bacterial Vaccines Product and Solutions
Table 16. Sanofi Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Bacterial Vaccines Major Business
Table 19. Merck Bacterial Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Bacterial Vaccines Product and Solutions
Table 22. Merck Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Emergent BioDefense Operations Lansing Corporate Information, Location and Competitors
Table 24. Emergent BioDefense Operations Lansing Bacterial Vaccines Major Business
Table 25. Emergent BioDefense Operations Lansing Bacterial Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. Emergent BioDefense Operations Lansing SWOT Analysis
Table 27. Emergent BioDefense Operations Lansing Bacterial Vaccines Product and Solutions
Table 28. Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GlaxoSmithKline Corporate Information, Location and Competitors
Table 30. GlaxoSmithKline Bacterial Vaccines Major Business
Table 31. GlaxoSmithKline Bacterial Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. GlaxoSmithKline SWOT Analysis
Table 33. GlaxoSmithKline Bacterial Vaccines Product and Solutions
Table 34. GlaxoSmithKline Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Serum Institute of India Corporate Information, Location and Competitors
Table 36. Serum Institute of India Bacterial Vaccines Major Business
Table 37. Serum Institute of India Bacterial Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Serum Institute of India SWOT Analysis
Table 39. Serum Institute of India Bacterial Vaccines Product and Solutions
Table 40. Serum Institute of India Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. PaxVax Corporate Information, Location and Competitors
Table 42. PaxVax Bacterial Vaccines Major Business
Table 43. PaxVax Bacterial Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. PaxVax SWOT Analysis
Table 45. PaxVax Bacterial Vaccines Product and Solutions
Table 46. PaxVax Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Bacterial Vaccines Revenue (Million USD) by Players (2015-2020)
Table 48. Global Bacterial Vaccines Revenue Share by Players (2015-2020)
Table 49. Global Bacterial Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Bacterial Vaccines Revenue Market Share by Regions (2015-2020)
Table 51. North America Bacterial Vaccines Revenue by Countries (2015-2020)
Table 52. North America Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Table 53. Europe Bacterial Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Bacterial Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Bacterial Vaccines Revenue by Countries (2015-2020)
Table 56. South America Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Bacterial Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Table 59. Global Bacterial Vaccines Revenue (Million USD) by Type (2015-2020)
Table 60. Global Bacterial Vaccines Revenue Share by Type (2015-2020)
Table 61. Global Bacterial Vaccines Revenue Forecast by Type (2021-2025)
Table 62. Global Bacterial Vaccines Revenue by Application (2015-2020)
Table 63. Global Bacterial Vaccines Revenue Share by Application (2015-2020)
Table 64. Global Bacterial Vaccines Revenue Forecast by Application (2021-2025)
Table 65. Global Bacterial Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Bacterial Vaccines Picture
Figure 2. Global Bacterial Vaccines Revenue Market Share by Type in 2019
Figure 3. Capsular Polysaccharide Vaccines Picture
Figure 4. Toxoid Vaccines Picture
Figure 5. Purified Protein Vaccines Picture
Figure 6. Live Attenuated Bacterial Vaccines Picture
Figure 7. Killed Bacterial Vaccines Picture
Figure 8. Others Picture
Figure 9. Bacterial Vaccines Revenue Market Share by Application in 2019
Figure 10. Hospital Pharmacies Picture
Figure 11. Retail Pharmacies Picture
Figure 12. Online Pharmacies Picture
Figure 13. Global Bacterial Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Bacterial Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Bacterial Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Bacterial Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Bacterial Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Bacterial Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Bacterial Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Bacterial Vaccines Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Bacterial Vaccines Revenue Market Share in 2019
Figure 22. Global Top 10 Players Bacterial Vaccines Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Bacterial Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Bacterial Vaccines Revenue Market Share by Regions (2015-2020)
Figure 26. Global Bacterial Vaccines Revenue Market Share by Regions in 2018
Figure 27. North America Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. Europe Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 30. South America Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. North America Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Figure 33. North America Bacterial Vaccines Revenue Market Share by Countries in 2019
Figure 34. USA Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 35. Canada Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. Europe Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Bacterial Vaccines Revenue Market Share by Countries in 2019
Figure 39. Germany Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. UK Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 41. France Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 42. Russia Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Italy Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Bacterial Vaccines Revenue Market Share by Countries in 2019
Figure 46. China Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. Japan Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 48. Korea Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 49. India Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. South America Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. South America Bacterial Vaccines Revenue Market Share by Countries in 2019
Figure 53. Brazil Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Bacterial Vaccines Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Bacterial Vaccines Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 58. UAE Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Bacterial Vaccines Revenue and Growth Rate (2015-2020)
Figure 61. Global Bacterial Vaccines Revenue Share by Type (2015-2020)
Figure 62. Global Bacterial Vaccines Revenue Share by Type in 2019
Figure 63. Global Bacterial Vaccines Market Share Forecast by Type (2021-2025)
Figure 64. Global Capsular Polysaccharide Vaccines Revenue Growth Rate (2015-2020)
Figure 65. Global Toxoid Vaccines Revenue Growth Rate (2015-2020)
Figure 66. Global Purified Protein Vaccines Revenue Growth Rate (2015-2020)
Figure 67. Global Live Attenuated Bacterial Vaccines Revenue Growth Rate (2015-2020)
Figure 68. Global Killed Bacterial Vaccines Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Bacterial Vaccines Revenue Share by Application (2015-2020)
Figure 71. Global Bacterial Vaccines Revenue Share by Application in 2019
Figure 72. Global Bacterial Vaccines Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 75. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 76. Global Bacterial Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Bacterial Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Bacterial Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Bacterial Vaccines Revenue Market Forecast (2021-2025)
Figure 80. Europe Bacterial Vaccines Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Bacterial Vaccines Revenue Market Forecast (2021-2025)
Figure 82. South America Bacterial Vaccines Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Bacterial Vaccines Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel